Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2003
05/22/2003WO2003041563A2 Neurotransmitter balance chemotherapy
05/22/2003WO2003020253A3 Pharmaceutical compositions for the treatment of asthma
05/22/2003WO2002102836A3 Moraxella (branhamella) catarrhalis antigens
05/22/2003WO2002100327A3 Substituted 1-benzazepines and derivatives thereof
05/22/2003WO2002096362A3 Method for treating fibrotic diseases or other indications vi
05/22/2003WO2002085886A3 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
05/22/2003WO2002044168A3 Indole-type inhibitors of p38 kinase
05/22/2003WO2002043719A3 Composition and method for treating snoring
05/22/2003WO2002030924A9 Quinazoline derivatives with anti-tumour activity
05/22/2003WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
05/22/2003US20030097023 For prophylaxis and therapy of immunological diseases, asthma, abnormal bone formation, neuronal cell death, lung failure, liver damage, acute hepatitis, nephritis, renal insufficiency, hypertension, myocardiac ischemia
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030097000 2-Phenyl-quinoline derivatives, preparation method and therapeutic use thereof
05/22/2003US20030096992 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
05/22/2003US20030096874 For prophylaxis and therapy of respiratory diseases asthma, chronic obstructive pulmonary disease (COPD), respiratory tract infection or upper respiratory tract disease
05/22/2003US20030096844 Cannabinoid receptor ligands
05/22/2003US20030096841 For treatment of cancers, heart disease, such as congestive heart failure, osteoporosis, genetic, inflammatory, allergic, and autoimmune diseases
05/22/2003US20030096840 Granule formulation
05/22/2003US20030096834 Pharmaceutical compositions
05/22/2003US20030096833 Use in inhibiting inflammation, cell death and in treating shock and reperfusion injuries
05/22/2003US20030096829 1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors
05/22/2003US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
05/22/2003US20030096819 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
05/22/2003US20030096817 Inhibiting mammalian protein kinases (p38) with (2,6-difluoro-phenyl)-(5-iodo-pyridin-2-yl)amine for treatment of cardiovascular disorders
05/22/2003US20030096816 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
05/22/2003US20030096812 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
05/22/2003US20030096811 Such as cis-(4-dimethylaminomethyl-3-hydroxy-3-(3-methoxy-phenyl)-cyclohexanone for treatment of pain, inflammation, allergies, depression, drug/alcohol abuse, gastritis, itching, cardiovascular/repiratory diseases, epilepsy, and diarrhea
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030096788 Adenosine derivatives
05/22/2003US20030096737 Caspase inhibitors and uses thereof
05/22/2003US20030096705 Antagonists of MCP-1 function and methods of use thereof
05/22/2003US20030096387 Contacting the isomerase with a compound having the structure: A-X-A, where A is radical which mimics the steric and electronic properties of phosphoserin and/or phosphothreonine residue, X= spacer, R is cyclic, heterocylic or aryl ring
05/22/2003US20030096370 Gram negative bacterial protein for use in the prevention and treatment of bacterial infection
05/22/2003US20030096338 Protein conjugate for use in the treatment of blood disorder
05/22/2003US20030096312 Novel natrium-calcium exchanger protein
05/22/2003US20030096297 Method for identifying inhibitors of G protein coupled receptor signaling
05/22/2003US20030096270 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders
05/22/2003US20030096029 Remedies for allergic diseases and process for producing the same
05/22/2003US20030096027 Alpha acid, (e.g., humulone) or beta acid (e.g., lupulone)
05/22/2003US20030096012 Film-forming powder, compositions containing it, methods for their preparation and their uses
05/22/2003US20030095973 Chlamydia antigens and corresponding DNA fragments and uses thereof
05/22/2003CA2784450A1 Polypeptides of pseudomonas aeruginosa
05/22/2003CA2467347A1 Histamine receptor h3 polynucleotides
05/22/2003CA2467267A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003CA2466665A1 Method to treat cystic fibrosis
05/22/2003CA2466521A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003CA2466465A1 Nk1 antagonists
05/22/2003CA2466440A1 Cannabinoid receptor ligands
05/22/2003CA2466355A1 Neurotransmitter balance chemotherapy
05/22/2003CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003CA2465893A1 Polycyclic guanine derivative phosphodiesterase v inhibitors
05/22/2003CA2464863A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
05/22/2003CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2464419A1 Benzimidazoles useful as protein kinase inhibitors
05/22/2003CA2464347A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2460959A1 Enzymes
05/21/2003EP1312675A1 Protein induced by homogeneous blood transfusion and dna encoding the same
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1312601A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
05/21/2003EP1312367A1 Heterocyclo-alkylsulfonyl pyrazolesa and their use as COX-2 inhibitors
05/21/2003EP1312356A1 Aqueous suspension preparations
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311663A2 Claudin polypeptides
05/21/2003EP1311534A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds
05/21/2003EP1311533A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311532A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311507A1 Fused pyrazole derivatives being protein kinase inhibitors
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311294A2 Formulations of mometasone and a bronchodilator for pulmonary administration
05/21/2003EP1311290A2 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
05/21/2003EP1311269A2 Method of using diketopiperazines and composition containing them
05/21/2003EP1311268A1 Imidazopyridine and imidazopyrimidine antiviral agents
05/21/2003EP1311263A2 Fused pyrrolocarbazoles against inflammation
05/21/2003EP1311259A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
05/21/2003EP1311255A1 Compounds having mif antagonist activity
05/21/2003EP1192161B1 Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands
05/21/2003EP1131334A4 Use of core 2 glcnac transferase inhibitors in treating inflammation
05/21/2003EP0866801B1 Cyclopeptolides
05/21/2003CN1419554A Process for preparing crystalline form 1 of cabergoline
05/21/2003CN1419552A 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1418688A Medicine composition for treating cold and cough, and its prepn. method
05/21/2003CN1418687A Medicine composite for treating cough
05/21/2003CN1418658A Traditional Chinese medicine prepn. for treating acute and chronic bronchitis, and its prepn. method
05/21/2003CN1418629A Tipepidine oral disintegrant for treating tussis and expectoration, and its prepn. method
05/21/2003CN1109046C Induction of cytotoxic T-lymphocyte responses
05/21/2003CN1109022C Arylalkanoyl pyridazines derivatives, its preparation method, medicine comprising samd and use thereof
05/21/2003CN1108967C Metering valve
05/21/2003CN1108813C Detoxicating stasis-dispersing inflammation-relieving antalgic and refreshing medicine and its preparing process
05/21/2003CN1108799C Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction
05/20/2003US6566554 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis
05/20/2003US6566526 Intermediates useful for the preparation of antihistaminic piperidine derivatives
05/20/2003US6566405 Drugs, cosmetics or dietary supplements; immunomodulation, antiallergens (IgE mediated allergies, e.g., asthma, rhinitis, eczema); anaphylaxis; autoimmune disorders, e.g., Crohn's disease, antiarthritic and ulcer agents; analgesics
05/20/2003US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/20/2003US6566376 Diphenyl-piperidine derivative
1 ... 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 ... 878